Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis

Atherosclerosis (AS) is a chronic inflammatory disease and leading cause of cardiovascular diseases. The progression of AS is a multi-step process leading to high morbidity and mortality. Hyperglycemia, dyslipidemia, advanced glycation end products (AGEs), inflammation and insulin resistance which s...

Full description

Bibliographic Details
Main Authors: Lin Mao, Ruili Yin, Longyan Yang, Dong Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.983723/full
_version_ 1817999406032486400
author Lin Mao
Ruili Yin
Longyan Yang
Dong Zhao
author_facet Lin Mao
Ruili Yin
Longyan Yang
Dong Zhao
author_sort Lin Mao
collection DOAJ
description Atherosclerosis (AS) is a chronic inflammatory disease and leading cause of cardiovascular diseases. The progression of AS is a multi-step process leading to high morbidity and mortality. Hyperglycemia, dyslipidemia, advanced glycation end products (AGEs), inflammation and insulin resistance which strictly involved in diabetes are closely related to the pathogenesis of AS. A growing number of studies have linked AGEs to AS. As one of the risk factors of cardiac metabolic diseases, dysfunction of VSMCs plays an important role in AS pathogenesis. AGEs are increased in diabetes, participate in the occurrence and progression of AS through multiple molecular mechanisms of vascular cell injury. As the main functional cells of vascular, vascular smooth muscle cells (VSMCs) play different roles in each stage of atherosclerotic lesions. The interaction between AGEs and receptor for AGEs (RAGE) accelerates AS by affecting the proliferation and migration of VSMCs. In addition, increasing researches have reported that AGEs promote osteogenic transformation and macrophage-like transformation of VSMCs, and affect the progression of AS through other aspects such as autophagy and cell cycle. In this review, we summarize the effect of AGEs on VSMCs in atherosclerotic plaque development and progression. We also discuss the AGEs that link AS and diabetes mellitus, including oxidative stress, inflammation, RAGE ligands, small noncoding RNAs.
first_indexed 2024-04-14T03:08:21Z
format Article
id doaj.art-7f2f407244c045f394da256e5f68d059
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-14T03:08:21Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-7f2f407244c045f394da256e5f68d0592022-12-22T02:15:40ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-08-011310.3389/fendo.2022.983723983723Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosisLin MaoRuili YinLongyan YangDong ZhaoAtherosclerosis (AS) is a chronic inflammatory disease and leading cause of cardiovascular diseases. The progression of AS is a multi-step process leading to high morbidity and mortality. Hyperglycemia, dyslipidemia, advanced glycation end products (AGEs), inflammation and insulin resistance which strictly involved in diabetes are closely related to the pathogenesis of AS. A growing number of studies have linked AGEs to AS. As one of the risk factors of cardiac metabolic diseases, dysfunction of VSMCs plays an important role in AS pathogenesis. AGEs are increased in diabetes, participate in the occurrence and progression of AS through multiple molecular mechanisms of vascular cell injury. As the main functional cells of vascular, vascular smooth muscle cells (VSMCs) play different roles in each stage of atherosclerotic lesions. The interaction between AGEs and receptor for AGEs (RAGE) accelerates AS by affecting the proliferation and migration of VSMCs. In addition, increasing researches have reported that AGEs promote osteogenic transformation and macrophage-like transformation of VSMCs, and affect the progression of AS through other aspects such as autophagy and cell cycle. In this review, we summarize the effect of AGEs on VSMCs in atherosclerotic plaque development and progression. We also discuss the AGEs that link AS and diabetes mellitus, including oxidative stress, inflammation, RAGE ligands, small noncoding RNAs.https://www.frontiersin.org/articles/10.3389/fendo.2022.983723/fullatherosclerosisdiabetes mellitusadvanced glycation end productsvascular smooth muscle cellsreceptor for advanced glycation end products
spellingShingle Lin Mao
Ruili Yin
Longyan Yang
Dong Zhao
Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
Frontiers in Endocrinology
atherosclerosis
diabetes mellitus
advanced glycation end products
vascular smooth muscle cells
receptor for advanced glycation end products
title Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
title_full Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
title_fullStr Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
title_full_unstemmed Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
title_short Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
title_sort role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
topic atherosclerosis
diabetes mellitus
advanced glycation end products
vascular smooth muscle cells
receptor for advanced glycation end products
url https://www.frontiersin.org/articles/10.3389/fendo.2022.983723/full
work_keys_str_mv AT linmao roleofadvancedglycationendproductsonvascularsmoothmusclecellsunderdiabeticatherosclerosis
AT ruiliyin roleofadvancedglycationendproductsonvascularsmoothmusclecellsunderdiabeticatherosclerosis
AT longyanyang roleofadvancedglycationendproductsonvascularsmoothmusclecellsunderdiabeticatherosclerosis
AT dongzhao roleofadvancedglycationendproductsonvascularsmoothmusclecellsunderdiabeticatherosclerosis